Ifp Advisors, Inc Jounce Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$5.04 - $8.73 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$6.58 - $10.66 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$6.73 - $13.87 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$6.37 - $10.33 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$4.58 - $10.95 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$4.17 - $7.58 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	SELL	$2.91 - $8.7 $2,866 - $8,569	-985 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$2.81 - $9.21 $2,767 - $9,071	985 New	985 $8,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.